Tag: Microbiology Scientist Award

Doug Chung | Biological Sciences | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Doug Chung | Biological Sciences | Best Researcher Award

Chungnam National University, South Korea

Dr. Doug Young Chung is a distinguished soil scientist with an accomplished academic and research career spanning over three decades. Dr. Chung has dedicated his professional life to advancing the field of soil science through education, research, and leadership. He has served as a Professor at Chungnam National University from October 1995 to August 2022, where he contributed significantly to both academic instruction and scientific innovation. His expertise lies primarily in soil physics and soil biophysics, with a research focus on soil management, erosion control, nutrient distribution, and sustainable agricultural practices. Dr. Chung has a robust publication record in reputable journals, particularly the Korean Journal of Agricultural Science, and is also the author of key textbooks on soil science and environmental sustainability. His leadership roles in professional societies and editorial positions further highlight his dedication to scientific excellence and community service. Dr. Chung’s comprehensive academic background, practical research outcomes, and strong mentorship contributions underscore his qualification as a leading researcher in his field. His work has had lasting impact on agricultural science in Korea and continues to inform sustainable land-use practices in coastal and reclaimed areas.

Professional Profile

Education

Dr. Doug Young Chung’s educational foundation is grounded in rigorous training in agronomy and soil science, obtained from prestigious institutions in both Korea and the United States. He began his academic journey with a Bachelor of Science degree in Agronomy from Konkuk University, Korea, completed in February 1983. His growing interest in the physical and biological properties of soil systems led him to pursue graduate studies abroad. He earned a Master of Science degree in Soil Science with a specialization in Soil Biophysics from Michigan State University in May 1987. This training enabled him to develop a deeper understanding of the interactions between soil physical properties and biological activity, particularly in relation to water retention and soil structure. In December 1993, he obtained his Ph.D. in Soil Science from Clemson University, specializing in Soil Physics. His doctoral work laid a critical foundation for his future research in soil erosion, salinity management, and nutrient dynamics in various agricultural landscapes. These academic achievements have provided Dr. Chung with a broad and interdisciplinary framework to address complex challenges in soil science and sustainable agriculture, and they continue to influence his scientific and pedagogical approach in professional practice.

Professional Experience

Dr. Doug Young Chung has an extensive and impactful professional career characterized by both academic excellence and industry collaboration. He began his research career as a Research Associate at the Korea Institute of Science and Technology (KIST) in 1994, followed by a similar position at Jinro Research Institute until 1995. His academic tenure commenced in October 1995 when he joined Chungnam National University as a professor in the Institute of Agricultural Science. Over the next 27 years, he played a vital role in educating undergraduate and graduate students while conducting pioneering research in soil science. His areas of instruction and mentorship spanned soil biophysics, environmental sustainability, and land reclamation. Between 2002 and 2004, he served as Editor-in-Chief of the Korean Journal of Soil Science and Fertilizer, demonstrating his leadership and editorial expertise. Furthermore, from 2003 to 2012, Dr. Chung served as Vice President of the Korean Society of Soil Science and Fertilizer, where he facilitated scientific dialogue and policy engagement. His dual experience in academia and industry has given him a balanced perspective on the practical applications of soil research, enabling him to influence agricultural practices, environmental management, and policy development in Korea and beyond.

Research Interest

Dr. Doug Young Chung’s research interests are centered around soil physics and biophysics, with a particular emphasis on sustainable land management and soil quality improvement. His work explores the physical behavior of soil under various environmental conditions, especially in the context of erosion control, nutrient cycling, and water retention. A significant part of his research has been devoted to understanding the dynamics of reclaimed tidal lands in Korea, such as the Saemangeum region, where he has investigated salinity management and organic matter enhancement through strategic crop cultivation. Dr. Chung is also interested in the application of models such as the van Genuchten equation for predicting soil water retention, with a focus on particle size effects, including materials like perlite. His research also addresses spatial variability of nutrients in different land-use systems, particularly at the interface of forest and agricultural lands. Furthermore, he examines how soil properties influence ecological functions and agricultural productivity, offering practical solutions to improve soil health. His interest in integrating traditional soil science with environmental monitoring and agricultural sustainability has made his work both regionally relevant and globally resonant, especially in light of climate change and food security challenges.

Research Skills

Dr. Doug Young Chung possesses a well-rounded set of research skills that span fieldwork, laboratory analysis, computational modeling, and scientific writing. His expertise in soil physics equips him with the ability to analyze complex soil-water-plant interactions, critical for understanding erosion, salinity, and organic matter dynamics. He is skilled in applying models such as the van Genuchten retention curve to evaluate water holding capacity in soils with different textural properties, including reclaimed and marginal lands. His field-based research involves soil sampling, texture classification, and environmental monitoring, which are essential for assessing soil fertility and degradation. In the laboratory, he is proficient in techniques related to soil moisture analysis, nutrient profiling, and structural stability. Moreover, Dr. Chung has strong capabilities in data interpretation and technical writing, evidenced by his numerous peer-reviewed journal articles and textbooks. His editorial leadership further highlights his meticulous attention to scientific clarity and accuracy. Additionally, his ability to design and implement long-term field trials showcases his project management and interdisciplinary collaboration skills. Collectively, these competencies enable Dr. Chung to conduct high-quality research that contributes meaningfully to soil science and agricultural sustainability.

Awards and Honors

While specific awards and honors are not detailed in the provided resume, Dr. Doug Young Chung’s appointments and leadership roles in academic societies speak volumes about the recognition he has received within the scientific community. His tenure as Editor-in-Chief of the Korean Journal of Soil Science and Fertilizer from 2002 to 2004 reflects the trust placed in him to uphold the standards of one of Korea’s most important agricultural journals. Additionally, his long-standing service as Vice President of the Korean Society of Soil Science and Fertilizer from 2003 to 2012 is indicative of his respected status among peers and his significant contributions to advancing soil science in Korea. His authorship of two key academic books, including Soil Science (2006) and Soils and Life (2014), suggests further recognition of his thought leadership in the field. Though no formal honors are listed, these achievements imply a high degree of peer esteem, academic influence, and national-level impact. Future documentation of international recognitions, conference awards, or citation metrics could further highlight his contributions and broaden his profile in global academic networks.

Conclusion

Dr. Doug Young Chung represents a model of academic excellence and dedication in the field of soil science. With over 30 years of professional experience, his contributions to education, research, and professional service are extensive and impactful. His scientific investigations into soil physical properties, erosion management, water retention, and nutrient dynamics have directly influenced agricultural practices and environmental management strategies in Korea, especially in challenging areas like reclaimed tidal lands. Through his roles in academic publishing and society leadership, Dr. Chung has helped shape the direction of soil science research and policy in his country. While further international collaboration and global recognition would enhance the reach of his work, his foundational research and educational impact are undeniable. His textbooks serve as important resources for students and practitioners alike, reflecting his commitment to knowledge dissemination. In summary, Dr. Chung’s career reflects a lifetime of contribution to soil science, making him a highly suitable candidate for recognition such as the Best Researcher Award. His work not only advances academic understanding but also contributes to solving real-world problems in agriculture and environmental sustainability.

Publications Top Notes

  1. Simple assessment of wind erosion depending on the soil texture and threshold wind velocity in reclaimed tidal flat land
    Authors: Chung et al.
    Year: 2016
    Journal: Korean Journal of Agricultural Science
  2. Estimation of Water Retention Characteristics Depending on the Particle Sizes of Perlite Using van Genuchten Equation with Retention Curve Program
    Authors: Chung et al.
    Year: 2021
    Journal: Korean Journal of Agricultural Science
  3. Distribution of Nitrogen and Phosphorus in Arable and Forest Stand along the Boundary of Upstream Daechung Reservoir
    Authors: Chung et al.
    Year: 2018
    Journal: Korean Journal of Agricultural Science
  4. Managing Soil Organic Matter and Salinity by Crop Cultivation in Saemangeum Reclaimed Tidal Land
    Authors: Chung et al.
    Year: 2020
    Journal: Korean Journal of Agricultural Science

Ghasem Solgi | Microbiology | Best Researcher Award

Published on by Shen Awards

Prof. Ghasem Solgi | Microbiology | Best Researcher Award

Professor of Immunology from Hamadan University of Medical Sciences, Iran

Dr. Ghasem Solgi is a seasoned medical immunologist with extensive experience in both academic and clinical research settings. Born in 1976 in Iran, he has dedicated over two decades to advancing the field of immunology, particularly in transplantation and immunogenetics. As the Head of the Immunogenetics Lab at Hamadan University of Medical Sciences, Dr. Solgi has played a pivotal role in shaping research in HLA-related immunology and autoimmune diseases. His research primarily investigates the role of HLA genes in disease susceptibility, treatment response, and transplant outcomes, contributing valuable insights to clinical immunology. Dr. Solgi’s leadership experience, including his tenure as Deputy for Research Affairs and Head of the Immunology Department, reflects his commitment to both scientific inquiry and academic governance. He has mentored numerous graduate and postgraduate students, actively participates in peer review for high-impact journals, and maintains membership in respected scientific societies. His multidisciplinary approach, which bridges immunogenetics, autoimmune diseases, and clinical transplant immunology, underscores the translational impact of his work. With an impressive history of scientific supervision and collaboration, Dr. Solgi continues to contribute to the global immunology community through both innovative research and the nurturing of future scholars.

Professional Profile

Education

Dr. Ghasem Solgi holds a strong academic foundation in medical immunology, shaped by rigorous training at renowned institutions. He earned his Ph.D. in Medical Immunology from Tehran University of Medical Sciences in 2009. His doctoral thesis focused on the effects of donor bone marrow cell infusion on microchimerism and allograft outcomes in kidney transplant patients, followed by a comprehensive five-year follow-up study—highlighting his early dedication to transplantation immunology. Prior to his doctoral studies, Dr. Solgi completed his M.Sc. in Medical Immunology at Isfahan University of Medical Sciences in 2002. His master’s thesis compared serological and DNA-based methods for HLA typing in kidney allograft recipients, laying the groundwork for his long-standing focus on HLA research. Further enriching his expertise, he undertook a practical course and thesis completion in Transplantation Immunology at IKT in Ulm, Germany, during 2008–2009. This international experience not only refined his technical skills but also exposed him to diverse scientific environments. Dr. Solgi’s educational trajectory demonstrates a consistent commitment to excellence in immunology, emphasizing both theoretical knowledge and hands-on laboratory experience. His academic preparation has been instrumental in shaping his career as a researcher, educator, and clinical immunology expert.

Professional Experience

Dr. Ghasem Solgi has accumulated a wealth of professional experience in academia and research since earning his doctoral degree. He currently serves as the Head of the Immunogenetics Lab in the Immunology Department at Hamadan University of Medical Sciences, a role he has held since 2020. From 2016 to 2020, he was the Deputy for Research Affairs of the Medical School, where he contributed to strategic planning and research development. Previously, between 2015 and 2019, he served as the Head of the Immunology Department at the same institution, reflecting his leadership capabilities and influence on departmental growth. Earlier in his career, Dr. Solgi worked as an Assistant Professor in the Immunology Department at Hamadan University (2012–2015) and Ahvaz Jundishapur University of Medical Sciences (2009–2012). These academic roles have allowed him to balance research, teaching, and mentorship, while advancing the university’s immunology programs. His career path demonstrates a steady progression of leadership in both scientific and administrative capacities. Through his sustained involvement in immunogenetics and autoimmune research, Dr. Solgi has cultivated a distinguished profile, earning respect from colleagues, students, and collaborators alike.

Research Interests

Dr. Ghasem Solgi’s research interests lie primarily in the field of immunogenetics and transplantation immunology, with a particular focus on the Human Leukocyte Antigen (HLA) system and its relationship to disease pathogenesis and therapeutic outcomes. His studies aim to understand how genetic and immunological factors influence immune responses in organ transplantation and autoimmune disorders. Specifically, he investigates the distribution of HLA alleles and haplotypes in diseases such as type 1 diabetes (T1D), multiple sclerosis (MS), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and their correlation with susceptibility, disease severity, and treatment response. Dr. Solgi has also examined the role of HLA in COVID-19, exploring genetic predisposition to disease severity. His transplantation research includes microchimerism analysis, anti-HLA antibody detection, and long-term survival of kidney transplant patients. These interdisciplinary topics combine clinical relevance with molecular insights, aiming to improve diagnosis, prognosis, and personalized treatment strategies. His dedication to integrating immunogenetic data with clinical outcomes has placed his research at the intersection of translational medicine and precision immunology. This comprehensive scope not only addresses pressing healthcare challenges but also contributes to evolving strategies in immunotherapy and transplant compatibility assessment.

Research Skills

Dr. Ghasem Solgi possesses a robust set of research skills that span molecular biology, immunogenetics, and clinical immunology. He has extensive expertise in HLA typing using both serological and DNA-based methods, which he applied early in his career and further developed through practical training in Germany. His technical proficiency includes flow cytometry, ELISA, PCR-based genotyping, and microchimerism analysis—essential tools for studying immune responses in transplant recipients and autoimmune patients. Dr. Solgi is skilled in study design, biostatistical analysis, and survival analysis, which are critical in assessing long-term patient outcomes in kidney transplantation. He is also experienced in conducting family-based genetic studies to evaluate allelic distribution in disease populations. His ability to integrate laboratory findings with clinical parameters demonstrates a high level of translational research competency. In addition, Dr. Solgi’s editorial contributions to numerous international journals reflect his critical appraisal skills and deep understanding of current scientific methodologies. His mentoring record further showcases his ability to transfer knowledge and guide complex research projects, making him not only a proficient investigator but also a collaborative academic leader in immunology and genetic research.

Awards and Honors

While specific awards are not explicitly listed in the available documentation, Dr. Ghasem Solgi’s professional trajectory and academic appointments reflect significant recognition and respect within the scientific community. His leadership roles—such as Head of the Immunogenetics Lab, Head of the Immunology Department, and Deputy for Research Affairs—demonstrate institutional trust and acknowledgment of his scientific contributions. Additionally, his long-standing memberships in prominent organizations such as the Iranian Society of Immunology and Allergy (since 2006) and the European Federation for Immunogenetics (since 2010) further signify professional standing. Dr. Solgi’s participation as a manuscript reviewer for more than a dozen respected journals, including Scientific Reports, Journal of Clinical Medicine, Human Immunology, and Diagnostics, underscores his expertise and influence in shaping contemporary immunological research. These editorial responsibilities are a form of professional recognition typically granted to well-established researchers. His record of supervising graduate and postgraduate students also reflects academic confidence in his mentorship and leadership. While formal awards could be added to enhance visibility, Dr. Solgi’s contributions, impact, and peer acknowledgment position him as a highly respected figure in his field.

Conclusion

Dr. Ghasem Solgi is a highly accomplished immunologist whose work bridges fundamental research and clinical application, particularly in the areas of transplantation immunology and immunogenetics. With an educational background grounded in top-tier Iranian institutions and complemented by international training, he has consistently demonstrated academic rigor and scientific curiosity. His professional roles across two leading Iranian universities, combined with his leadership of research labs and departments, reveal a strong commitment to advancing medical science and nurturing future experts. Dr. Solgi’s research has yielded valuable insights into the HLA system’s role in autoimmune diseases and transplant outcomes, contributing to the development of more effective diagnostic and therapeutic strategies. He possesses strong technical and analytical research skills, and his involvement in numerous peer-reviewed journals speaks to his academic credibility. Although additional international awards or collaborations would further elevate his profile, the depth and impact of his work firmly establish him as a deserving nominee for the Best Researcher Award. Dr. Solgi’s enduring contributions to immunology, combined with his leadership and mentorship, make him a vital asset to both the academic community and the broader field of clinical research.

Publications Top Notes

  1. Chemical Contamination in the Extracted DNA Affects the Results of HLA Typing by the PCR-SSOP Method

  • Authors: A. Shirizadeh, M. Ebrahimpur, S. Soltani, G. Solgi

  • Journal: Molecular Biology Reports

  • Year: 2025

  • Citations: 2

  1. A Potential Link Between HLA-DRB1/DQB1 Alleles and Response to Treatment in Rheumatoid Arthritis Patients

  • Authors: A. Tahamoli-Roudsari, A. Rasouli-Saravani, Z. Basiri, M. Hajilooei, G. Solgi

  • Journal: International Journal of Immunogenetics

  • Year: 2025

  1. Potential Contribution of Gut Microbiota in the Development of Autoantibodies in T1D Children Carrying HLA-DRB1/DQB1 Risk Alleles: An Experimental and In Silico Analysis

  • Authors: A. Shirizadeh, Z. Razavi, V. Saeedi, J. Faradmal, G. Solgi

  • Journal: Immunogenetics

  • Year: 2024

  • Citations: 1

  1. MicroRNA -21 Expression as an Auxiliary Diagnostic Biomarker of Acute Brucellosis

  • Authors: M. Rezaeepoor, F. Keramat, S. Jourghasemi, M. Hajilooei, G. Solgi

  • Journal: Molecular Biology Reports

  • Year: 2024

  1. Peripheral Blood Mononuclear Cells Show Markers of Mitochondrial Dysfunction in Rheumatoid Arthritis

  • Authors: A. Abbasifard, G. Solgi, I. Khodadadi, H. Tayebinia, A. Fazaeli

  • Journal: Cell Biochemistry and Function

  • Year: 2024

  • Citations: 1

  1. Determination of HLA Class II Risk Alleles and Prediction of Self/Non-Self-Epitopes Contributing Hashimoto’s Thyroiditis in a Group of Iranian Patients

  • Authors: A. Shirizadeh, S. Borzouei, Z. Razavi, J. Faradmal, G. Solgi

  • Journal: Immunogenetics

  • Year: 2024

  1. Family-Based Association of HLA-DRB1 and DQB1 Alleles and Haplotypes in a Group of Iranian Type 1 Diabetes Children

  • Authors: A. Shirizadeh, Z. Razavi, V. Saeedi, G.E. Morahan, G. Solgi

  • Journal: HLA

  • Year: 2024

  • Citations: 3

  1. Epigenetic Regulation of FOXP3 Gene Expression in Relation to Impaired Function of Regulatory T Cells in Systemic Lupus Erythematosus

  • Authors: P. Fakour, A. Shirizadeh, A. Tahamoli-Roudsari, G. Solgi

  • Journal: Not specified

  • Citations: 1

 

Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Published on by Shen Awards

Prof. Dr. Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Head of Research Group at Blood Transfusion Centre of Slovenia, Slovenia

Vladka Čurin Šerbec is an accomplished researcher and academic with a robust background in biochemistry, molecular biology, and immunology. With extensive experience in both academic and industrial settings, she has made significant contributions to the development of monoclonal antibodies, diagnostics, and therapeutics. Through her leadership roles, including serving as the President of the Immunology Society of Slovenia, she has influenced research in the fields of immunology and biomedicine. Her research also involves collaborations with pharmaceutical industries, leading to the development of new technologies and successful commercialization of research outcomes. Known for her mentorship of numerous students and professionals, Čurin Šerbec is a respected figure in the scientific community, contributing to the education and growth of future researchers.

Professional Profile

Education

Vladka Čurin Šerbec’s academic journey began with a BChem degree from the University of Ljubljana in 1985. She continued her studies at the same institution, obtaining a Master’s degree in Biochemistry in 1988, followed by a PhD in 1991. Throughout her education, she focused on the molecular and biochemical aspects of biology, laying the foundation for her future research in immunology and biomedicine. This strong academic background has propelled her into various prestigious positions within both academia and industry, making her a leading figure in her field.

Professional Experience

Vladka Čurin Šerbec has a distinguished career that spans several decades, beginning with her research at the Jožef Stefan Institute and the Ruđer Bošković Institute in the 1980s and 1990s. Since 1993, she has held various key positions at the Blood Transfusion Centre of Slovenia (BTCS), including Head of the Department for the Production of Diagnostic Reagents and Research, Scientific Counsellor, and Vice-President of the Supervisory Board. Additionally, she served as an Associate Professor and later a Professor at the University of Ljubljana’s Medical Faculty. Her leadership in industrial and academic collaborations has been instrumental in advancing research in immunology and biomedicine.

Research Interests

Vladka Čurin Šerbec’s research interests are centered around biochemistry, molecular biology, immunology, and the development of monoclonal antibodies for diagnostic and therapeutic purposes. Her work focuses on the production of diagnostic reagents and antibodies under GMP conditions, exploring new approaches to immunological diagnostics and treatments. Additionally, she has been involved in collaborative research with the pharmaceutical industry, contributing to the development of technologies with real-world applications. Her interest in the standardization and quality assessment of immunological diagnostics has also been pivotal to her contributions to the field.

Research Skills

Vladka Čurin Šerbec possesses a broad skill set in molecular biology, biochemistry, and immunology. Her expertise includes the development and production of monoclonal antibodies, diagnostic reagents, and research tools. She is skilled in various laboratory techniques and methodologies, including immunoassays, molecular cloning, and protein expression. Additionally, Čurin Šerbec has significant experience in project leadership, having led multiple industrial, national, and international research initiatives. Her work also involves the development of biotechnological applications, such as antibody-based diagnostics and therapeutics, in close collaboration with pharmaceutical companies.

Awards and Honors

Vladka Čurin Šerbec has received numerous awards throughout her career in recognition of her scientific achievements. Notably, she was awarded the Zois Award in 2002 for her technological innovations and contributions to the field of biochemistry. She also received the Krka Award for students in organic chemistry in 1983, highlighting her early promise as a researcher. Čurin Šerbec’s achievements have been widely acknowledged by the scientific community, and her work continues to inspire future generations of researchers. She has also been honored with leadership positions in international societies, further solidifying her reputation in the field of immunology.

Conclusion

This individual demonstrates outstanding research capabilities and leadership in the fields of biochemistry, molecular biology, and immunology. Their substantial achievements in the development of monoclonal antibodies and collaborations with industry reflect both scientific excellence and practical contributions. Their commitment to research mentoring and international collaboration further strengthens their position for recognition in research excellence. With continued focus on expanding their publication record and global research influence, they have the potential for even greater impact in the scientific community.

Publication Top Notes

  1. Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases
    • Authors: Song, F., Kovac, V., Mohammadi, B., Curin Serbec, V., Altmeppen, H.C.
    • Year: 2024
    • Journal: Acta Neuropathologica
    • Volume: 148(1), Pages 2
  2. Optimizing the method for expressing human monoclonal antibodies from a single peripheral blood cell from vaccinated donors
    • Authors: Omejec, S., Tompa, M., Kovač, V., Šerbec, V.Č.
    • Year: 2024
    • Journal: Journal of Immunological Methods
    • Volume: 534, Article 113747
  3. Prion Protein: The Molecule of Many Forms and Faces
    • Authors: Kovač, V., Šerbec, V.Č.
    • Year: 2022
    • Journal: International Journal of Molecular Sciences
    • Volume: 23(3), Article 1232
    • Citations: 21
  4. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone
    • Authors: Šelb, J., Rijavec, M., Eržen, R., Lyons, J.J., Korošec, P.
    • Year: 2021
    • Journal: Journal of Allergy and Clinical Immunology
    • Volume: 148(2), Pages 621–626.e7
    • Citations: 36
  5. Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases
    • Authors: Kovač, V., Čurin Šerbec, V.
    • Year: 2018
    • Journal: Biomarker Insights
    • Volume: 13
    • Citations: 6
  6. Targeting malignant brain tumors with antibodies
    • Authors: Razpotnik, R., Novak, N., Curin Šerbec, V., Rajcevic, U.
    • Year: 2017
    • Journal: Frontiers in Immunology
    • Volume: 8(SEP), Article 1181
    • Citations: 57
  7. Truncated prion protein PrP226 – A structural view on its role in amyloid disease*
    • Authors: Kovač, V., Zupančič, B., Ilc, G., Plavec, J., Čurin Šerbec, V.
    • Year: 2017
    • Journal: Biochemical and Biophysical Research Communications
    • Volume: 484(1), Pages 45–50
    • Citations: 10
  8. New monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma
    • Authors: Košir, A.B., Lukan, T., Kukovec, M., Šerbec, V.Č., Rajčević, U.
    • Year: 2017
    • Journal: Zdravniski Vestnik
    • Volume: 86(5-6), Pages 177–184
  9. Anchorless forms of prion protein – Impact of truncation on structure destabilization and prion protein conversion
    • Authors: Kovač, V., Hafner-Bratkovič, I., Čurin Šerbec, V.
    • Year: 2016
    • Journal: Biochemical and Biophysical Research Communications
    • Volume: 481(1-2), Pages 1–6
    • Citations: 10
  10. Flavonoid interaction with a chitinase from grape berry skin: Protein identification and modulation of the enzymatic activity
    • Authors: Filippi, A., Petrussa, E., Rajcevic, U., Vianello, A., Braidot, E.
    • Year: 2016
    • Journal: Molecules
    • Volume: 21(10), Article 1300
    • Citations: 9

 

 

De-Wei Lai | Microbiology | Best Scholar Award

Published on by Shen Awards

Prof. Dr. De-Wei Lai | Microbiology | Best Scholar Award

Associate Researcher at Taichung Veterans General Hospital, Taiwan

Dr. De-Wei Lai is an accomplished Associate Researcher at the Department of Medical Research, Taichung Veterans General Hospital, Taiwan. With a strong foundation in applied chemistry and immunology, he has dedicated his career to unraveling the complexities of regulatory T cells in diverse pathological conditions. Dr. Lai’s research spans autoimmunity, regenerative medicine, and the tumor microenvironment, with a focus on innovative immunotherapeutic strategies. His expertise integrates modern molecular techniques with natural extracts and traditional Chinese medicine, aiming to develop novel diagnostic and therapeutic solutions. With over 19 SCI/SCIE-indexed publications, 27 editorial appointments, and 16 awards, Dr. Lai has established himself as a leading voice in immunological research. His work, characterized by precision and translational potential, continues to shape the future of immunotherapy.

Professional Profile

Education

Dr. De-Wei Lai completed his undergraduate studies in Applied Chemistry at National Pingtung University, where he developed a deep interest in cellular metabolism and biochemical signaling pathways. He later pursued a Ph.D. in Immunology, focusing on the molecular mechanisms underlying diabetic retinopathy, which culminated in a groundbreaking publication in Circulation Research. His academic journey is marked by excellence in understanding complex immunological pathways and leveraging this knowledge for practical medical applications.

Professional Experience

Dr. Lai began his research career in 2019 at Chang Bing Show Chwan Memorial Hospital, where he studied the isolation, cultivation, and functional analysis of regulatory T cells (Tregs). His work laid the foundation for significant advancements in immunotherapy. In 2024, he joined Taichung Veterans General Hospital, where he expanded his focus to include molecular mechanisms of Tregs in autoimmune diseases, regenerative medicine, and tumor microenvironments. Throughout his career, Dr. Lai has consistently contributed to high-impact research, addressing critical gaps in clinical immunology and advancing innovative therapeutic strategies.

Research Interests

Dr. Lai’s research interests lie at the intersection of immunotherapy, molecular biology, and regenerative medicine. His laboratory explores the molecular mechanisms of regulatory T cells in autoimmune diseases, age-related degenerative conditions, and cancer. Recently, Dr. Lai has extended his work to study the potential of natural extracts, traditional Chinese medicine, and metal-organic nanoparticles as modulators of the immune system. By integrating experimental models with clinical big data, his research aims to develop novel diagnostic tools and immunotherapeutic strategies that address pressing medical challenges.

Research Skills

Dr. Lai possesses a robust skill set in immunological research and molecular biology. His expertise includes regulatory T cell isolation and expansion, animal model development for autoimmune diseases, and the study of tumor microenvironments. He is proficient in advanced techniques such as flow cytometry, immunohistochemistry, and molecular signaling analysis. His interdisciplinary approach also incorporates the evaluation of natural compounds and nanoparticles for therapeutic applications. With strong analytical skills and an eye for innovation, Dr. Lai excels in bridging basic research with translational medicine.

Awards and Honors

Dr. Lai’s contributions to immunological research have been widely recognized. He has received 16 awards and recognitions, highlighting his impact in both academic and clinical settings. These honors reflect his groundbreaking discoveries in T cell biology, innovative therapeutic approaches, and commitment to advancing immunotherapy. His editorial appointments in 27 journals and conferences further underscore his standing in the scientific community as a trusted authority in immunological research. Dr. Lai’s dedication to addressing clinical challenges continues to earn him accolades and inspire future research efforts.

Conclusion

Dr. De-Wei Lai is an excellent candidate for the Best Scholar Award due to his exceptional research achievements, dedication to addressing clinical challenges, and innovative approach to immunotherapy. While he excels in academic publication and editorial roles, areas like project leadership, patents, and international collaborations offer room for growth. Overall, his contributions to immunology and translational medicine make him a strong contender for this recognition.

Publications Top Notes

  • Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain‐mediated C/EBP β and NF κ B cleavage
    • Authors: SM Wu, WY Lin, CC Shen, HC Pan, W Keh‐Bin, YC Chen, YJ Jan, DW Lai, …
    • Journal: Journal of Pineal Research, 60 (2), 142-154
    • Year: 2016
    • Citations: 98
  • Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress, and inhibiting epithelial-to-mesenchymal transition
    • Authors: SH Liu, WJ Lee, DW Lai, SM Wu, CY Liu, HR Tien, CS Chiu, YC Peng, …
    • Journal: Molecular Oncology, 9 (4), 834-849
    • Year: 2015
    • Citations: 64
  • Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model
    • Authors: HC Pan, DW Lai, KH Lan, CC Shen, SM Wu, CS Chiu, KB Wang, …
    • Journal: Carcinogenesis, 34 (11), 2568-2579
    • Year: 2013
    • Citations: 45
  • Aryl hydrocarbon receptor deficiency attenuates oxidative stress-related mesangial cell activation and macrophage infiltration and extracellular matrix accumulation in diabetic nephropathy
    • Authors: WJ Lee, SH Liu, CK Chiang, SY Lin, KW Liang, CH Chen, HR Tien, …
    • Journal: Antioxidants & Redox Signaling, 24 (4), 217-231
    • Year: 2016
    • Citations: 44
  • The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination
    • Authors: DW Lai, SH Liu, AI Karlsson, WJ Lee, KB Wang, YC Chen, CC Shen, …
    • Journal: Oncotarget, 5 (17), 7788
    • Year: 2014
    • Citations: 43
  • Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways
    • Authors: CS Chiu, CH Tsai, MS Hsieh, SC Tsai, YJ Jan, WY Lin, DW Lai, SM Wu, …
    • Journal: Cancer Letters, 442, 113-125
    • Year: 2019
    • Citations: 42
  • TPL2 (therapeutic targeting tumor progression locus-2)/ATF4 (activating transcription factor-4)/SDF1α (chemokine stromal cell-derived factor-α) axis suppresses diabetic retinopathy
    • Authors: DW Lai, KH Lin, WHH Sheu, MR Lee, CY Chen, WJ Lee, YW Hung, …
    • Journal: Circulation Research, 121 (6), e37-e52
    • Year: 2017
    • Citations: 37
  • Attenuation of in vitro and in vivo melanin synthesis using a Chinese herbal medicine through the inhibition of tyrosinase activity
    • Authors: SC Liu, ML Sheu, YC Tsai, YC Lin, CW Chang, DW Lai
    • Journal: Phytomedicine, 95, 153876
    • Year: 2022
    • Citations: 22
  • Melatonin protects retinal integrity through mediated immune homeostasis in the sodium iodate-induced mouse model of age-related macular degeneration
    • Authors: LC Ku, ML Sheu, HH Cheng, CY Lee, YC Tsai, CY Tsai, KH Lin, LC Lai, …
    • Journal: Biomedicine & Pharmacotherapy, 161, 114476
    • Year: 2023
    • Citations: 10
  • AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression
    • Authors: HH Cheng, L Hung‐Ke, ML Sheu, CY Lee, YC Tsai, DW Lai
    • Journal: Immunology, 168 (4), 654-670
    • Year: 2023
    • Citations: 8